Ran, Wei
Li, Shuzhen
Yuan, Ruixue
Luo, Huan
Li, Ping
Gao, Jin
Funding for this research was provided by:
National Key Clinical Specialty Construction Project (No. 2011-170)
Article History
Received: 18 April 2022
Accepted: 8 December 2022
First Online: 20 December 2022
Declarations
:
: This study (IRB number: 2019–338) was approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University on April 23, 2021 and registered at the Chinese Clinical Trial Registry (ExternalRef removed, Clinical trial registration number: ChiCTR2100045711) before the enrollment process started on April 28, 2021. This study adhered to the CONSORT guidelines. All methods were conducted in accordance with the Declaration of Helsinki, and written informed consent was obtained from all patients prior to the study. Patients received no compensation for taking part in the experiment.
: Not applicable.
: The authors declare that there are no conflicts of interest.